These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8274586)

  • 21. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of DST and TRH test administration on depression assessments: a controlled study.
    Lafer B; Fava M; Hammerness P; Rosenbaum JF
    Biol Psychiatry; 1993 Nov; 34(9):650-3. PubMed ID: 8292694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of dexamethasone on plasma homovanillic acid and 3-methoxy-4-hydroxyphenylglycol. Evidence for abnormal corticosteroid-catecholamine interactions in major depression.
    Wolkowitz OM; Doran AR; Breier A; Roy A; Jimerson DC; Sutton ME; Golden RN; Paul SM; Pickar D
    Arch Gen Psychiatry; 1987 Sep; 44(9):782-9. PubMed ID: 3632251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A preliminary study of the relationship among personality, cognitive vulnerability, symptom profile, and outcome in major depressive disorder.
    Scott J; Harrington J; House R; Ferrier IN
    J Nerv Ment Dis; 1996 Aug; 184(8):503-5. PubMed ID: 8752080
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma catecholamine metabolites in subtypes of major depression.
    Mazure CM; Bowers MB; Hoffman F; Miller KB; Nelson JC
    Biol Psychiatry; 1987 Dec; 22(12):1469-72. PubMed ID: 3676373
    [No Abstract]   [Full Text] [Related]  

  • 26. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
    De Bellis MD; Geracioti TD; Altemus M; Kling MA
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiglucocorticoid treatment of refractory depression with ketoconazole: a case report.
    Anand A; Malison R; McDougle CJ; Price LH
    Biol Psychiatry; 1995 Mar; 37(5):338-40. PubMed ID: 7748987
    [No Abstract]   [Full Text] [Related]  

  • 28. A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia.
    Hellerstein DJ; Yanowitch P; Rosenthal J; Samstag LW; Maurer M; Kasch K; Burrows L; Poster M; Cantillon M; Winston A
    Am J Psychiatry; 1993 Aug; 150(8):1169-75. PubMed ID: 8328559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use.
    Wolfersdorf M; Barg T; König F; Leibfarth M; Grünewald I
    Pharmacopsychiatry; 1995 Mar; 28(2):56-60. PubMed ID: 7624387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dexamethasone suppression test and the levels of serum growth hormone, plasma vasopressin and plasma homovanillic acid in depressed in- and outpatients.
    Syvälahti E
    Acta Psychiatr Scand; 1985 Feb; 71(2):105-10. PubMed ID: 3976406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paroxetine and amitriptyline in the treatment of depression in general practice.
    Christiansen PE; Behnke K; Black CH; Ohrström JK; Bork-Rasmussen H; Nilsson J
    Acta Psychiatr Scand; 1996 Mar; 93(3):158-63. PubMed ID: 8739658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortisol synthesis inhibition: a new treatment strategy for the clinical and endocrine manifestations of depression.
    Thakore JH; Dinan TG
    Biol Psychiatry; 1995 Mar; 37(6):364-8. PubMed ID: 7772644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antidepressant guidelines poorly adhered to in young people].
    de Vries YA; de Jonge P; Kalverdijk L; Bos HJ; Schuiling-Veninga CC; Hak E
    Ned Tijdschr Geneeskd; 2016; 160():D627. PubMed ID: 27552937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of electroconvulsive treatment on monoamine metabolites, growth hormone, and prolactin in plasma.
    Linnoila M; Litovitz G; Scheinin M; Chang MD; Cutler NR
    Biol Psychiatry; 1984 Jan; 19(1):79-84. PubMed ID: 6200149
    [No Abstract]   [Full Text] [Related]  

  • 36. Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.
    Mårtensson B; Nyberg S; Toresson G; Brodin E; Bertilsson L
    Acta Psychiatr Scand; 1989 Jun; 79(6):586-96. PubMed ID: 2475012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of quality of life in the treatment of major depressive disorder with fluoxetine, 20 mg, in ambulatory patients aged over 60 years.
    Mesters P; Cosyns P; Dejaiffe G; Fanielle J; Gilles C; Godderis J; Grégoire J; de Leval N; Meire P; Mesotten F
    Int Clin Psychopharmacol; 1993; 8(4):337-40. PubMed ID: 8277160
    [No Abstract]   [Full Text] [Related]  

  • 38. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
    J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of fluoxetine on anxiety and depression symptoms in cancer patients.
    Razavi D; Allilaire JF; Smith M; Salimpour A; Verra M; Desclaux B; Saltel P; Piollet I; Gauvain-Piquard A; Trichard C; Cordier B; Fresco R; Guillibert E; Sechter D; Orth JP; Bouhassira M; Mesters P; Blin P
    Acta Psychiatr Scand; 1996 Sep; 94(3):205-10. PubMed ID: 8891089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of oral dextroamphetamine on plasma cortisol in major depressive disorder.
    Myers ED
    Biol Psychiatry; 1989 Oct; 26(6):634-6. PubMed ID: 2675990
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.